Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Homogeneous substrate-labeled fluorescent immunoassay for carbamazepine

T M Li, J E Miller, F E Ward

    Epilepsia
    |August 1, 1982
    PubMed
    Summary

    A new homogeneous substrate-labeled fluorescent immunoassay (SLFIA) accurately measures carbamazepine levels in human serum. This method provides reliable therapeutic drug monitoring for epilepsy management, ensuring patient safety and treatment efficacy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A Pilot Study Examining Elements to Improve Generalized Word Reading Skills for Students With Significant Word Reading Difficulties.

    Journal of learning disabilities·2026
    Same author

    Effect of feeding a blackseed meal-sericea lespedeza leaf meal pellet on gastrointestinal nematode and coccidia infection and animal performance in young goats.

    Veterinary parasitology·2024
    Same author

    Clinical and technical factors in endoscopic skull base surgery associated with reconstructive success.

    Rhinology·2024
    Same author

    Enlarged Mesenteric Gland and an Aneurism of the Anterior Mesenteric Artery.

    The Journal of comparative medicine and veterinary archives·2022
    Same author

    Prevalence and risk factors associated with intestinal parasitic infections among schoolchildren in Punjab, Pakistan.

    Tropical biomedicine·2021
    Same author

    A Comparison of Regularized Maximum-Likelihood, Regularized 2-Stage Least Squares, and Maximum-Likelihood Estimation with Misspecified Models, Small Samples, and Weak Factor Structure.

    Multivariate behavioral research·2020

    Area of Science:

    • Clinical Chemistry
    • Analytical Chemistry
    • Biochemistry

    Background:

    • Carbamazepine is an anticonvulsant vital for epilepsy treatment.
    • Its narrow therapeutic range necessitates precise serum monitoring to prevent toxicity.
    • Existing monitoring methods can be complex or time-consuming.

    Purpose of the Study:

    • To develop a homogeneous substrate-labeled fluorescent immunoassay (SLFIA) for carbamazepine quantification in human serum.
    • To establish a sensitive, reliable, and convenient method for therapeutic drug monitoring.
    • To validate the SLFIA assay against established analytical techniques.

    Main Methods:

    • Synthesis of a carbamazepine fluorogenic reagent (FR).
    • Utilizing beta-galactosidase for enzymatic hydrolysis producing fluorescence.

    Related Experiment Videos

  • Measuring fluorescence inhibition based on carbamazepine competition for antibody binding.

    • Main Results:

    • The SLFIA assay demonstrated low within-run (1.6-5.5%) and between-run (1.9-3.5%) coefficients of variation.
    • Assay results showed strong correlation with High-Performance Liquid Chromatography (HPLC) (r=0.97), Enzyme Immunoassay (r=0.98), and Gas Chromatography (GC) (r=0.95).
    • The assay provides a sensitive and reproducible method for carbamazepine measurement.

    Conclusions:

    • The developed homogeneous SLFIA is a viable and accurate method for therapeutic drug monitoring of carbamazepine.
    • This assay offers a convenient alternative for clinical laboratories managing epilepsy patients.
    • SLFIA provides reliable carbamazepine serum concentrations, aiding in optimizing patient treatment and safety.